Ozakbas, S. Et Al. 2022. Immune response against SARS-CoV-2 vaccines in treatment-naive multiple sclerosis patients. 38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis , (Amsterdam, Netherlands), 776.

Ozakbas, S., Baba, C., SAMADZADE, U., KAYA, E., ÖZÇELİK, S., Özdoğar, A. T., ... DOĞAN, Y.(2022). Immune response against SARS-CoV-2 vaccines in treatment-naive multiple sclerosis patients . 38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (pp.776). Amsterdam, Netherlands

Ozakbas, SERKAN Et Al. "Immune response against SARS-CoV-2 vaccines in treatment-naive multiple sclerosis patients," 38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, Amsterdam, Netherlands, 2022

Ozakbas, SERKAN Et Al. "Immune response against SARS-CoV-2 vaccines in treatment-naive multiple sclerosis patients." 38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis , Amsterdam, Netherlands, pp.776, 2022

Ozakbas, S. Et Al. (2022) . "Immune response against SARS-CoV-2 vaccines in treatment-naive multiple sclerosis patients." 38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis , Amsterdam, Netherlands, p.776.

@conferencepaper{conferencepaper, author={SERKAN ÖZAKBAŞ Et Al. }, title={Immune response against SARS-CoV-2 vaccines in treatment-naive multiple sclerosis patients}, congress name={38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis}, city={Amsterdam}, country={Netherlands}, year={2022}, pages={776} }